Billable / Specific Code
ICD-10-CM Z79.633 is the diagnosis code for Long term (current) use of mitotic inhibitor. This code falls under the section "Persons with potential health hazards related to family and personal history and certain conditions influencing health status" within Chapter 21 — Factors influencing health status and contact with health services (Z00-Z99). It is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Understanding where Z79.633 sits in the ICD-10-CM classification helps ensure proper coding:
Yes, Z79.633 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Z79.633 is the ICD-10-CM diagnosis code for "Long term (current) use of mitotic inhibitor". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of Z79.633 is Z79.63 ("Long term (current) use of chemotherapeutic agent"). Z79.633 provides a more specific classification within this category.
Z79.633 is located in Section Z77-Z99 — "Persons with potential health hazards related to family and personal history and certain conditions influencing health status" within Chapter 21 of the ICD-10-CM Tabular List.
Use Z79.633 when the patients documented diagnosis matches "Long term (current) use of mitotic inhibitor" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Long term (current) use of mitotic inhibitor is Z79.633.
Yes, Z79.633 can be used as a primary diagnosis code since it is billable and specific.
Z79.633 is in Chapter 21 of the ICD-10-CM Tabular List.
Yes, Z79.633 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.